I work as part of the MS research team carrying out commercial and academic studies. I am also involved in the biology of MS and novel imaging techniques.
et al., 2019, Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials, Multiple Sclerosis Journal, Vol:25, ISSN:1352-4585, Pages:1462-1471
et al., 2019, Confirmation of specific binding of the 18 kDa translocator protein (TSPO) radioligand [18F]GE-180: a blocking study using XBD173 in multiple sclerosis normal appearing white and grey matter, Molecular Imaging and Biology, Vol:21, ISSN:1536-1632, Pages:935-944
et al., 2019, Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis, Proceedings of the National Academy of Sciences of the United States of America, Vol:116, ISSN:0027-8424, Pages:11020-11027
et al., 2019, Soluble CD27 a biomarker of T cell activity in intrathecal inflammation in patients with relapsing-remitting multiple sclerosis, 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SAGE PUBLICATIONS LTD, Pages:110-111, ISSN:1352-4585
et al., 2019, Predictors of long term brain atrophy among multiple sclerosis patients, 5th Congress of the European-Academy-of-Neurology (EAN), WILEY, Pages:247-247, ISSN:1351-5101